Home > Insider Trading > Filing (0001759655-22-000207)

Filing Details

Accession Number:: 0001759655-22-000207
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-12-20 16:08:24
Reporting Period:: 2022-10-05

Accepted Time:: 2022-12-20 16:08:24
Original Submission Date:: 2022-10-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759655	Privia Health Group Inc.	PRVA	Services-Health Services (8000)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1858396	David Mountcastle	Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington VA 22203	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.01 Par Value Per Share	Acquisiton	2022-10-05	4,167	$2.00	163,362	No	4	M	Direct
Common Stock, $0.01 Par Value Per Share	Disposition	2022-10-05	3,667	$35.63	159,695	No	4	S	Direct
Common Stock, $0.01 Par Value Per Share	Disposition	2022-10-05	500	$36.02	159,195	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On October 6, 2022, the reporting person filed a Form 4 (the "Original Form 4") which incorrectly reported that, following his exercise of an option and sales of the underlying common stock, he directly held 91,371 shares of the issuer's common stock. This amendment on Form 4/A is being filed to correct the number of shares as reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction" in each row of Table I of the Original Form 4. As a result of the error, the direct holdings of the reporting person was understated by 67,824 shares in a subsequent Form 4 filed by the reporting person. As of the date of this amendment, the reporting person directly beneficially owns 215,062 shares of common stock
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.00 to $36.04 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.